Article Versions
Export Article
Cite this article
  • Normal Style
  • MLA Style
  • APA Style
  • Chicago Style
Research Article
Open Access Peer-reviewed

Hantavirus Disease: An Emerging and Re-Emerging Viral Disease of Public Health Concern

Mahendra Pal , Kirubel Paulos Gutama
American Journal of Infectious Diseases and Microbiology. 2024, 12(1), 19-22. DOI: 10.12691/ajidm-12-1-4
Received January 19, 2024; Revised February 20, 2024; Accepted February 28, 2024

Abstract

Emergence and re-emergence of viral zoonoses pose a serious threat to human and animal health. Hantaviruses are enveloped negative (-) single-stranded RNA viruses that belong to Hantaviridae family, which are transmitted to humans through inhalation and are harbored by small rodents. Humans can develop two clinical syndromes as a result of hantavirus infection: haemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS), which are caused by Old World and New World hantaviruses, respectively. Infections with the hantavirus are rather common in peoples in parts of Asia, Europe, and South America, although they appear to be less common in North America. Globally, 200,000 peoples are affected with Hantaviruses every year. The clinical manifestations of HFRS range from asymptomatic to mild to moderate to severe. In general, HFRS produced by Hantaan, Amur, and Dobrava viruses is more severe, with fatality rates ranging from 5 to 15%, whereas Seoul, Puumala, and Saaremaa viruses induce mild types of disease with mortality rates of less than 1%, resulting in HCPS. For hantavirus identification, a variety of techniques are utilized, including polymerase chain reaction (PCR), focus reduction neutralization test (FRNT), enzyme-linked immunosorbent assay (ELISA), immunoblot assay (IBA), immunofluorescence assay (IFA), and other molecular approaches. Because no effective medication or vaccination has been licensed by the FDA, the greatest defense is to avoid contact with rodents and clean up rodent habitats safely.

1. Introduction

Emerging and re-emerging diseases caused by a variety of pathogens are a significant cause of morbidity and mortality in humans as well as in animals worldwide 1, 2. Hantaviruses, also known as Orthohantaviruses, are an emerging public health issue that appears to be spread by small rodents. It is estimated that Hantavirus are responsible to affect around 200,200 people globally annually 3. The disease has been reported from many countries of the world 4, 5, 6, 7. Hantaviruses are negative (-) ssRNA encapsulated viruses that belong to the family Hantaviridae 8. Hantavirus infection garnered international notice during the Korean War (1950–1953), despite the fact that a condition resembling it was documented 900 years before in Chinese texts 9. Hantaviruses prevalent in Europe and Asia, commonly known as Old World Hantaviruses, cause HFRS 10, whereas Hantavirus Pulmonary Syndrome (HPS) is caused by New World Hantaviruses found in America 11.

Humans are not in the native host range of hantaviruses, and the infection is usually caused by inhaling virus-containing aerosols from rodent excretions such urine, feces, and saliva 12, 13. People who live or work in close proximity to infected rodents are more likely to become infected, with animal trappers, mammalogists, forestry workers, farmers, and military personnel being the most vulnerable 14.

Hantavirus ecology and geographic distribution are linked to the spread of their natural reservoir 9. Over 28 hantaviruses that cause disease in humans have been detected around the world, ranging from acute renal failure to pulmonary oedema and severe hemorrhagic sickness. Because Hantaviral infections are often unrecognized and unreported in many areas, new hantaviruses may go unidentified 15. The objective of this review is to discuss the growing importance of Hantavirus infection as a global public health issue.

2. Etiology

Hantaviruses are members of the Orthohantavirus genus, which belongs to the family Hantaviridae and the Bunyavirales order 16. They are enclosed RNA viruses with a diameter of 80 to 120 nm and a spherical form. The genome is made up of three single-stranded negative sense RNAs that share a 30-terminal sequence of genome segments. The nucleoprotein (N), envelope glycoproteins (Gn and Gc), and the L protein, or viral RNA-dependent RNA polymerase, are encoded by the three segments, S (small), M (medium), and L (large) 17. Hantaviruses have been detected in rodents of family Muridae and the subfamilies Murinae, Arvicolinae, and Sigmodontinae in Asia, Europe, and the Americas 15. Heat (30 minutes at 60°C), detergents, UV irradiation, organic solvents, and hypochlorite solutions are all effective in inactivating Hantaviruses 18.

3. Transmission

Hantaviruses are thought to be spread by aerosolized rat excreta. Close contact between infected and naive rodents is likely to be the mode of transmission. Hantaviruses can be found in the saliva, feces, and urine of rodents. Fighting, biting, and sexual activity have all been suggested as possible modes of transmission. Hantavirus infection has recently been documented in a variety of domestic animal species (e.g., pigs, cats, rabbits, and dogs) 12, 19. Hantaviruses are considered to be transmitted to humans by contact with diseased rats or their excreta 12. Inhaling aerosolized dust from rat urine, droppings, or nests disturbed in an enclosed location appears to cause many diseases. Hantaviruses can also enter the body through broken skin, the conjunctiva, and other mucous membranes, as well as rodent bites and ingestion. In South America, the possibility of transmission through breast milk has been hypothesized 16. Cat can get infected from the rodents and act as a potential reservoir. There seems to be hardly any published information of human-to-human transmission 12.

4. Epidemiology

Murid rodents (order Rodentia; family Muridae; subfamilies Murinae, Arvicolinae, and Sigmodontinae) are the principal natural reservoir for hantaviruses 20. Humans are not in the natural host range of Hantaviruses; thus, the infection happens accidentally. People who live or work in close proximity to diseased rodents are more likely to become infected 12, 21. Old World viruses such as Hantaan, Puumala, Dobrava-Belgrade, Seoul, Amur-Soochong, and Gou viruses cause HFRS and are primarily carried by Murinae rodents in Europe and Asia; New World viruses such as SNV, New York-1 virus (NY-1V), and ANDV that cause HPS and are primarily carried by Sigmodontinae sub-family members in America; Hantaviruses reported both in Old or New World and related with mild disease include PUUV or Prospect Hill virus (PHV) and Tula virus (TULV) (non-virulent hantaviruses) are hosted by Arvicolinae rodents 22.

Hantaviruses are found all over the world, but their distribution is constrained by the geographic range of their reservoir hosts 16. The genus Hantavirus is divided into two groups: Old World hantaviruses and New World hantaviruses. Human HFRS is caused by pathogenic Old-World hantaviruses such as Amur virus, Seoul virus, and HTNV, the most epidemiologically important species in Asia, with mortality rates of up to 15%, and Dobrava virus (DOBV), Tula virus (TULV), and Puumala virus (PUUV) in Europe; the latter is the main Hantavirus species in Europe and causes nephropathiaepidemica (NE), a milder variant of HFRS 14, 20. In the early 1990s, the first pathogenic New World Hantavirus (Sin Nombre virus) was found in the United States' Four Corners region 23. New World hantaviruses are the cause of about 300 cases of HPS in North and South America each year, with mortality rates of up to 50% 24. The first serological evidence of hantavirus infections was discovered in Africa in 1984 25. Human hantavirus infections have been confirmed using serological tests since then 26. In endemic areas, several factors such as ecology of rodents, environment, human behaviors may influence the transmission and epidemiology of Hantaviruses 27.

5. Clinical Spectrum

5.1. In Humans

Humans can develop one of two clinical syndromes as a result of hantavirus infection: HFRS or HCPS, which are caused by Old World or New World hantaviruses, respectively 28. The clinical manifestations of HFRS range from asymptomatic to mild, moderate, and severe, depending in part on the disease's causative agent 11. A typical HFRS course can be broken down into five stages: febrile, hypotensive, oliguric, polyureic, and convalescent. After a 2- to 4-week incubation period, the sickness manifests itself with a high fever, chills, headache, backache, abdominal aches, nausea, and vomiting. Visual disturbances (blurred vision) and somnolence are common complaints 29. The clinical course of HCPS is divided into three stages: prodromal, cardiopulmonary, and convalescent, with symptoms ranging from mild hypoxia to respiratory failure with cardiogenic shock 30. In HPS, pulmonary symptoms are the most common. Similar to the prodromal stage of HFRS, this syndrome is characterized by a vague illness that lasts 3 to 5 days. Cough and tachypnea are generally followed by pulmonary edema and indications of hypoxia, indicating respiratory distress and hypotension. There may also be cardiac irregularities such as bradycardia, ventricular tachycardia, or fibrillation 16.

5.2. In Animals

In their reservoir hosts, hantaviruses are not associated with overt illness. However, studies have found that some wild mice and voles had poorer survival rates and weight growth. When domesticated rodents are experimentally infected with some viruses, they may develop clinical symptoms or lesions. In some of these experiments, infant rats and mice acquired severe diseases, including deadly meningoencephalitis. In most investigations, rats and mice above the age of 2-3 weeks were unharmed, while other species, such as Syrian hamsters, have shown varied clinical symptoms, including pulmonary and renal dysfunction. Laboratory rodents are given relatively high doses of virus by injection, which may or may not mirror natural hantavirus exposure. No clinical signs or lesions have been reported in pet rats naturally infected with Seoul virus 16.

6. Diagnosis

Clinical and epidemiological data, as well as laboratory tests, are used to diagnose HFRS and HCPS 31. Serology is used to diagnose acute hantavirus infections since nearly all patients exhibit IgM and, in most cases, IgG antibodies in their serum at the onset of symptoms. Indirect IgM and IgG ELISAs, as well as IgM capture ELISAs, which offer higher specificity than indirect ELISAs, are the most often used serological assays. Indirect immunofluorescence assays are also commonly employed in diagnostics; however, their specificity is lower 32. RT-PCR identification of the hantavirus genome in blood or serum samples can also confirm hantavirus infection. To identify viraemia, both standard and quantitative RT-PCR are utilized 33. Although the presence of viraemia varies, if an acute sample is available, viral RNA may typically be found. Furthermore, the presence of viral RNA has proven hantavirus infection even before the appearance of particular antibodies 34. The importance of kidney biopsy in the diagnosis of Hantvirus hemorrhagic fever with renal syndrome has been described by Lupusoru and co-investigators 35.

7. Treatment

There are currently no antiviral drugs that can be used to treat hantavirus infections. 3. Patients with HFRS or HPS are treated with supportive therapies to keep their symptoms under control, which can be life-threatening. Patients are usually monitored and cared for in an emergency department or intensive care unit until their immune systems have eliminated the virus and the convalescent phase begins 18. In some cases of HFRS, ribavirin has been reported to be beneficial. In a recent clinical experiment in South America, the administration of antiserum against hantaviruses appeared to be promising 11.

8. Prevention and Control

Preventive methods include avoiding contact with hantavirus-infected rodents and their excrement, urine, significant emissions, and tissues 8, 12. Depending on the conditions, this could include gloves, rain boots, goggles, coveralls or an entire suit, as well as a respirator 12, 36. Rodent-proofing of homes, decrease of rodent cover surrounding houses, minimizing of food available for rats, capturing of rodents in and around dwellings, and careful disposal of deceased rodents are all CDC recommendations 37. Anyone who develops a febrile infection on a regular basis with early signs of hantavirus pulmonary syndrome or hemorrhagic fever with renal syndrome should seek medical attention right once and advise their doctor about the global risk. While treating patients infected with ANDV, both all-encompassing precautions and droplet preventive measures are currently recommended 38. Apart from usual precautions, effective vaccines may be the only approach to reduce the risk of hantavirus disease. Commercial inactivated vaccines for HFRS caused by the Hantavirus and/or the Seoul virus are available in South Korea and China 16.

9. Conclusion

Hantavirus infections are one of an emerging zoonotic infectious disease. Small rodents host hantaviruses, which enter the human body through inhalation. Hantaviruses are old viruses, despite the fact that some have recently been discovered. However, environmental changes may impact the geographic distribution, abundance, and dynamics of the carrier rodent species, and hence the epidemiology of hantavirus disease. Despite the fact that we can only speculate on the extent of future environmental and climatic changes, hantavirus infections will continue to be a public health issue. As a result, more study into the pathophysiology, diagnosis, antiviral, and vaccine development of hantaviruses is required.

Contribution of Authors

Both authors contributed equally.

Conflict of Interest

No conflict of interest.

References

[1]  Pal, M. Importance of zoonoses in public health. Ind J Ani Sci, 2005, 75, 586-591.
In article      
 
[2]  Pal, M. Public health concern due to emerging and re-emerging zoonoses. Internat J Livest Res, 2013, 3, 56-62.
In article      View Article
 
[3]  Afzal, S., Ali, L., Batool, A., Afzal, M., Kanwal, N., Hassan, M., Safdar, M., Ahmed, A. and Yang, J.. Hantavirus: an overview and advancements in therapeutic approaches for infection. Front Microbiol, 2023; 14.
In article      View Article  PubMed
 
[4]  Llah, S. T., Mir, S., Sharif, S., Khan, S. and Mir, M. A. Hantavirus induced cardiopulmonary syndrome: a public health concern. J. Med. Virol.2018, 90, 1003–1009.
In article      View Article  PubMed
 
[5]  Avšič- Županc, T., Saksida, A. and Korva, M. Hantavirus infections. Clin Microbiol Infect, 2019, 21S: e6–e16.
In article      View Article  PubMed
 
[6]  Warner, B. M., Dowhanik, S., Audet, J., Grolla, A., Dick, D., Strong, J. E. and Kobasa, L.R. L. Hantavirus cardiopulmonary syndrome in Canada. Emerg. Infect. Dis. 2020, 26:3020.
In article      View Article  PubMed
 
[7]  Hautala, N., Partanen, T., Kubin, A.M., Kauma, H. and Hautala T. Central nervous system and ocular manifestations in Puumala Hantavirus infection. Viruses ,2021, 13:1040.
In article      View Article  PubMed
 
[8]  Munir, N., Jahangeer, M. and Hussain, S. Hantavirus diseases pathophysiology, their diagnostic strategies and therapeutic approaches: A review. Clini Exper Pharma Physio, 2021, 48:20–34.
In article      View Article  PubMed
 
[9]  Lee, H., Lee, P. and Johnson, K. Isolation of the etiologic agent of Korean hemorrhagic fever. J Infect Dis, 1978, 137, 298-308.
In article      View Article  PubMed
 
[10]  Lin, X., Guo, W. and Wang, W. Migration of Norway rats resulted in the worldwide distribution of Seoul hanta virus today. J Vir, 2012, 86, 972-981.
In article      View Article  PubMed
 
[11]  Jonsson, C., Figueiredo, L. and Vapalahti, O. A global perspective on hantavirus secology, epidemiology, and disease. Clini Microbiol Rev, 2010, 23, 412e41.
In article      View Article  PubMed
 
[12]  Pal, M. Zoonoses. 2nd Ed. Satyam Publishers, 2007, Jaipur, India.
In article      
 
[13]  Bi, Z., Formenty, P. and Roth, C. Hantavirus infection: a review and global update. J Infect Developi Countr, 2008, 2, 3–23.
In article      View Article  PubMed
 
[14]  Vapalahti, O., Mustonen, J., Lundkvist, A., Henttonen, H., Plyusnin, A. and Vaheri, A. Hantavirus infections in Europe. Lancet Infect Dis, 2003, 3, 653–661.
In article      View Article  PubMed
 
[15]  Peters, C., Mills, J., Spiropoulou, C., Zaki, S. and Rollin, P. Hantaviruses. (1998). In: Guerrant RL, Walker DH, Weller PF, eds. Tropical infectious diseases: principles, pathogens, and practice. New York: WB Saunders.
In article      
 
[16]  Schmalijohn, C .S. and Dalyrmple, J. M. Analysis of Hantaan virus RNA: evidence for a new genus of bunyaviridae. Virology 1983,131(2):482-91.
In article      View Article  PubMed
 
[17]  Rovid, A. Hantavirus.retr. .2018.
In article      
 
[18]  Gavrilovskaya, I., Shepley, M., Shaw, R., Ginsberg, M. and Mackow, E. (1998). Beta3 integrins mediate the cellular entry of Hantaviruses that cause respiratory failure. Procede Nat Acad Sci United States of America, 1998, 95, 7074–9.
In article      View Article  PubMed
 
[19]  Zhang, Y. Discovery of Hantaviruses in bats and insectivores and the evolution of the genus Hantavirus. Virus Research, 2014, 187, 15-21.
In article      View Article  PubMed
 
[20]  Maes, P., Clement, J., Gavrilovskaya, I. and Van Ranst, M. Hantaviruses: Immunology, treatment, and prevention. Viral Immunology, 2004, 17, 481–497.
In article      View Article  PubMed
 
[21]  Deutz, A., Fuchs, K., Schuller, W., Nowotny, N., Auer, H., Aspock, H., Stunzner, D., Kerbl, U., Klement, C. and Kofer, J. Seroepidemiological studies of zoonotic infections in hunters in southeastern Austria—Prevalences, risk factors, and preventive methods. Berl Munch Tierarztl Wochenschr, 2003, 116, 306– 311.
In article      
 
[22]  Meyer, B. and Schmaljohn, C. Persistent hantavirus infections: characteristics and mechanisms. Trends Microbiol, 2000, 8, 61-67.
In article      View Article  PubMed
 
[23]  Hjelle, B., Jenison, S., Torrez-Martinez, N., Yamada, T., Nolte, K., Zumwalt, R., MacInnes, K. and Myers, G. A novel hantavirus associated with an outbreak of fatal respiratory disease in the southwestern United States: Evolutionary relationships to known hantaviruses. J Virolo, 1994, 68, 592–596.
In article      View Article  PubMed
 
[24]  Muranyi, W., Bahr, U., Zeier, M. and Fokko, J. Hantavirus Infection. J Americ Soci Nephrol, 2005, 16, 3669–3679.
In article      View Article  PubMed
 
[25]  Gonzalez, J., McCormick, J., Baudon, D., Gautun, J., Meunier, D and Dournon, E. Serological evidence for Hantaan-related virus in Africa. Lancet, 1984, 2, 1036-1037.
In article      View Article  PubMed
 
[26]  Vial, P.A., Ferres, M., Vial, C., Klingstrom, J., Ahlm, C., Lopez R., Le Corre, N. and Mertz, G.J. Hantavirus in humans: a review of clinical aspects and management The Lancet Infectious Diseases, 2023, 23 (9) , pp. e371-e382.
In article      View Article  PubMed
 
[27]  Botros, B., Sobh, M., Wierzba, T., Arthur, R., Mohareb, E. and Frenck, R. Prevalence of hantavirus antibody in patients with chronic renal disease in Egypt. Transact Royal Soci Tropi Med Hygiene, 2004, 98, 331-336.
In article      View Article  PubMed
 
[28]  Khaiboullina, S., Morzunov, S. and Jeor S. Hantaviruses: molecular biology, evolution and pathogenesis. Curr Mol Med, 2005, 5, 773e90.
In article      View Article  PubMed
 
[29]  McCaughey, C. and Hart, C. Hantaviruses. J Med Microbio, 2004,49, 587e99.
In article      View Article  PubMed
 
[30]  Enria, D., Briggiler, A., Pini, N. and Levis, S. Clinical manifestations of new world hantaviruses. Cur Top Microbiol Immun, 2001, 256, 117–34.
In article      View Article  PubMed
 
[31]  Heyman, P., Vaheri, A., Lundkvist, A. and Avsic-Zupanc, T. Hantavirus infections in Europe: from virus carriers to a major public-health problem. Expert Rev Anti-infective Therapy, 2009, 7, 205e17.
In article      View Article  PubMed
 
[32]  Terajima, M., Hayasaka, D., Maeda, K. and Ennis, F. Immunopathogenesis of hantavirus pulmonary syndrome and hemorrhagic fever with renal syndrome: do CD8þ T cells trigger capillary leakage in viral hemorrhagic fevers? Immunology, 2007, 113, 117e20.
In article      View Article  PubMed
 
[33]  Ahn, C., Cho, J., Lee, J., Lim, C., Kim, Y. and Han, J. Detection of Hantaan and Seoul viruses by reverse transcriptase-polymerase chain reaction (RT-PCR) and restriction fragment length polymorphism (RFLP) in renal syndrome patients with hemorrhagic fever. Clin Nephrology, 2000, 53, 79e89.
In article      
 
[34]  Evander, M., Eriksson, I., Pettersson, L., Juto, P., Ahlm, C. and Olsson, G. (2007). Puumala hantavirus viremia diagnosed by real-time reverse transcriptase PCR using samples from patients with hemorrhagic fever and renal syndrome. J Clin Microbiol, 2007, 45, 2491e7.
In article      View Article  PubMed
 
[35]  Lupuşoru, G., Lupuşoru, M., Ailincăi, I., Bernea, L, Berechet, A., Spătaru, R. and Ismail G. Hanta hemorrhagic fever with renal syndrome: A pathology in whose diagnosis kidney biopsy plays a major role (review). Exp Ther Med, 2021, 22 (984).
In article      View Article  PubMed
 
[36]  Zhang, Y., Zou, Y., Fu, Z. and Plyusnin, A. Hantavirus infections in humans and animals, China. Emerg Infect Dis, 2010, 16, 1195.
In article      View Article  PubMed
 
[37]  CDC. Hantavirus infection—southwestern United States: interim recommendations for risk reduction. MMWR Recomm Rep; 2018, 42(RR-11), 1–13.
In article      
 
[38]  Malinin, O. and Platonov, A. Insufficient efficacy and safety of intravenous ribavirin in treatment of haemorrhagic fever with renal syndrome caused by Puumala virus. Infect Dis, 2017, 49,514-520.
In article      View Article  PubMed
 

Published with license by Science and Education Publishing, Copyright © 2024 Mahendra Pal and Kirubel Paulos Gutama

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/

Cite this article:

Normal Style
Mahendra Pal, Kirubel Paulos Gutama. Hantavirus Disease: An Emerging and Re-Emerging Viral Disease of Public Health Concern. American Journal of Infectious Diseases and Microbiology. Vol. 12, No. 1, 2024, pp 19-22. https://pubs.sciepub.com/ajidm/12/1/4
MLA Style
Pal, Mahendra, and Kirubel Paulos Gutama. "Hantavirus Disease: An Emerging and Re-Emerging Viral Disease of Public Health Concern." American Journal of Infectious Diseases and Microbiology 12.1 (2024): 19-22.
APA Style
Pal, M. , & Gutama, K. P. (2024). Hantavirus Disease: An Emerging and Re-Emerging Viral Disease of Public Health Concern. American Journal of Infectious Diseases and Microbiology, 12(1), 19-22.
Chicago Style
Pal, Mahendra, and Kirubel Paulos Gutama. "Hantavirus Disease: An Emerging and Re-Emerging Viral Disease of Public Health Concern." American Journal of Infectious Diseases and Microbiology 12, no. 1 (2024): 19-22.
Share
[1]  Pal, M. Importance of zoonoses in public health. Ind J Ani Sci, 2005, 75, 586-591.
In article      
 
[2]  Pal, M. Public health concern due to emerging and re-emerging zoonoses. Internat J Livest Res, 2013, 3, 56-62.
In article      View Article
 
[3]  Afzal, S., Ali, L., Batool, A., Afzal, M., Kanwal, N., Hassan, M., Safdar, M., Ahmed, A. and Yang, J.. Hantavirus: an overview and advancements in therapeutic approaches for infection. Front Microbiol, 2023; 14.
In article      View Article  PubMed
 
[4]  Llah, S. T., Mir, S., Sharif, S., Khan, S. and Mir, M. A. Hantavirus induced cardiopulmonary syndrome: a public health concern. J. Med. Virol.2018, 90, 1003–1009.
In article      View Article  PubMed
 
[5]  Avšič- Županc, T., Saksida, A. and Korva, M. Hantavirus infections. Clin Microbiol Infect, 2019, 21S: e6–e16.
In article      View Article  PubMed
 
[6]  Warner, B. M., Dowhanik, S., Audet, J., Grolla, A., Dick, D., Strong, J. E. and Kobasa, L.R. L. Hantavirus cardiopulmonary syndrome in Canada. Emerg. Infect. Dis. 2020, 26:3020.
In article      View Article  PubMed
 
[7]  Hautala, N., Partanen, T., Kubin, A.M., Kauma, H. and Hautala T. Central nervous system and ocular manifestations in Puumala Hantavirus infection. Viruses ,2021, 13:1040.
In article      View Article  PubMed
 
[8]  Munir, N., Jahangeer, M. and Hussain, S. Hantavirus diseases pathophysiology, their diagnostic strategies and therapeutic approaches: A review. Clini Exper Pharma Physio, 2021, 48:20–34.
In article      View Article  PubMed
 
[9]  Lee, H., Lee, P. and Johnson, K. Isolation of the etiologic agent of Korean hemorrhagic fever. J Infect Dis, 1978, 137, 298-308.
In article      View Article  PubMed
 
[10]  Lin, X., Guo, W. and Wang, W. Migration of Norway rats resulted in the worldwide distribution of Seoul hanta virus today. J Vir, 2012, 86, 972-981.
In article      View Article  PubMed
 
[11]  Jonsson, C., Figueiredo, L. and Vapalahti, O. A global perspective on hantavirus secology, epidemiology, and disease. Clini Microbiol Rev, 2010, 23, 412e41.
In article      View Article  PubMed
 
[12]  Pal, M. Zoonoses. 2nd Ed. Satyam Publishers, 2007, Jaipur, India.
In article      
 
[13]  Bi, Z., Formenty, P. and Roth, C. Hantavirus infection: a review and global update. J Infect Developi Countr, 2008, 2, 3–23.
In article      View Article  PubMed
 
[14]  Vapalahti, O., Mustonen, J., Lundkvist, A., Henttonen, H., Plyusnin, A. and Vaheri, A. Hantavirus infections in Europe. Lancet Infect Dis, 2003, 3, 653–661.
In article      View Article  PubMed
 
[15]  Peters, C., Mills, J., Spiropoulou, C., Zaki, S. and Rollin, P. Hantaviruses. (1998). In: Guerrant RL, Walker DH, Weller PF, eds. Tropical infectious diseases: principles, pathogens, and practice. New York: WB Saunders.
In article      
 
[16]  Schmalijohn, C .S. and Dalyrmple, J. M. Analysis of Hantaan virus RNA: evidence for a new genus of bunyaviridae. Virology 1983,131(2):482-91.
In article      View Article  PubMed
 
[17]  Rovid, A. Hantavirus.retr. .2018.
In article      
 
[18]  Gavrilovskaya, I., Shepley, M., Shaw, R., Ginsberg, M. and Mackow, E. (1998). Beta3 integrins mediate the cellular entry of Hantaviruses that cause respiratory failure. Procede Nat Acad Sci United States of America, 1998, 95, 7074–9.
In article      View Article  PubMed
 
[19]  Zhang, Y. Discovery of Hantaviruses in bats and insectivores and the evolution of the genus Hantavirus. Virus Research, 2014, 187, 15-21.
In article      View Article  PubMed
 
[20]  Maes, P., Clement, J., Gavrilovskaya, I. and Van Ranst, M. Hantaviruses: Immunology, treatment, and prevention. Viral Immunology, 2004, 17, 481–497.
In article      View Article  PubMed
 
[21]  Deutz, A., Fuchs, K., Schuller, W., Nowotny, N., Auer, H., Aspock, H., Stunzner, D., Kerbl, U., Klement, C. and Kofer, J. Seroepidemiological studies of zoonotic infections in hunters in southeastern Austria—Prevalences, risk factors, and preventive methods. Berl Munch Tierarztl Wochenschr, 2003, 116, 306– 311.
In article      
 
[22]  Meyer, B. and Schmaljohn, C. Persistent hantavirus infections: characteristics and mechanisms. Trends Microbiol, 2000, 8, 61-67.
In article      View Article  PubMed
 
[23]  Hjelle, B., Jenison, S., Torrez-Martinez, N., Yamada, T., Nolte, K., Zumwalt, R., MacInnes, K. and Myers, G. A novel hantavirus associated with an outbreak of fatal respiratory disease in the southwestern United States: Evolutionary relationships to known hantaviruses. J Virolo, 1994, 68, 592–596.
In article      View Article  PubMed
 
[24]  Muranyi, W., Bahr, U., Zeier, M. and Fokko, J. Hantavirus Infection. J Americ Soci Nephrol, 2005, 16, 3669–3679.
In article      View Article  PubMed
 
[25]  Gonzalez, J., McCormick, J., Baudon, D., Gautun, J., Meunier, D and Dournon, E. Serological evidence for Hantaan-related virus in Africa. Lancet, 1984, 2, 1036-1037.
In article      View Article  PubMed
 
[26]  Vial, P.A., Ferres, M., Vial, C., Klingstrom, J., Ahlm, C., Lopez R., Le Corre, N. and Mertz, G.J. Hantavirus in humans: a review of clinical aspects and management The Lancet Infectious Diseases, 2023, 23 (9) , pp. e371-e382.
In article      View Article  PubMed
 
[27]  Botros, B., Sobh, M., Wierzba, T., Arthur, R., Mohareb, E. and Frenck, R. Prevalence of hantavirus antibody in patients with chronic renal disease in Egypt. Transact Royal Soci Tropi Med Hygiene, 2004, 98, 331-336.
In article      View Article  PubMed
 
[28]  Khaiboullina, S., Morzunov, S. and Jeor S. Hantaviruses: molecular biology, evolution and pathogenesis. Curr Mol Med, 2005, 5, 773e90.
In article      View Article  PubMed
 
[29]  McCaughey, C. and Hart, C. Hantaviruses. J Med Microbio, 2004,49, 587e99.
In article      View Article  PubMed
 
[30]  Enria, D., Briggiler, A., Pini, N. and Levis, S. Clinical manifestations of new world hantaviruses. Cur Top Microbiol Immun, 2001, 256, 117–34.
In article      View Article  PubMed
 
[31]  Heyman, P., Vaheri, A., Lundkvist, A. and Avsic-Zupanc, T. Hantavirus infections in Europe: from virus carriers to a major public-health problem. Expert Rev Anti-infective Therapy, 2009, 7, 205e17.
In article      View Article  PubMed
 
[32]  Terajima, M., Hayasaka, D., Maeda, K. and Ennis, F. Immunopathogenesis of hantavirus pulmonary syndrome and hemorrhagic fever with renal syndrome: do CD8þ T cells trigger capillary leakage in viral hemorrhagic fevers? Immunology, 2007, 113, 117e20.
In article      View Article  PubMed
 
[33]  Ahn, C., Cho, J., Lee, J., Lim, C., Kim, Y. and Han, J. Detection of Hantaan and Seoul viruses by reverse transcriptase-polymerase chain reaction (RT-PCR) and restriction fragment length polymorphism (RFLP) in renal syndrome patients with hemorrhagic fever. Clin Nephrology, 2000, 53, 79e89.
In article      
 
[34]  Evander, M., Eriksson, I., Pettersson, L., Juto, P., Ahlm, C. and Olsson, G. (2007). Puumala hantavirus viremia diagnosed by real-time reverse transcriptase PCR using samples from patients with hemorrhagic fever and renal syndrome. J Clin Microbiol, 2007, 45, 2491e7.
In article      View Article  PubMed
 
[35]  Lupuşoru, G., Lupuşoru, M., Ailincăi, I., Bernea, L, Berechet, A., Spătaru, R. and Ismail G. Hanta hemorrhagic fever with renal syndrome: A pathology in whose diagnosis kidney biopsy plays a major role (review). Exp Ther Med, 2021, 22 (984).
In article      View Article  PubMed
 
[36]  Zhang, Y., Zou, Y., Fu, Z. and Plyusnin, A. Hantavirus infections in humans and animals, China. Emerg Infect Dis, 2010, 16, 1195.
In article      View Article  PubMed
 
[37]  CDC. Hantavirus infection—southwestern United States: interim recommendations for risk reduction. MMWR Recomm Rep; 2018, 42(RR-11), 1–13.
In article      
 
[38]  Malinin, O. and Platonov, A. Insufficient efficacy and safety of intravenous ribavirin in treatment of haemorrhagic fever with renal syndrome caused by Puumala virus. Infect Dis, 2017, 49,514-520.
In article      View Article  PubMed